PAREXEL INTERNATIONAL CORPORATION Inactive Instrument
Company PAREXEL International Corporation
Equities
US6994621075
Biotechnology & Medical Research
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
Gregory Rush
DFI | Director of Finance/CFO | 56 | - |
Amy McKee
CTO | Chief Tech/Sci/R&D Officer | 52 | 31/12/18 |
Michael Crowley
ADM | Chief Administrative Officer | - | 31/12/08 |
Jonathan Shough
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/22 |
Peyton Howell
COO | Chief Operating Officer | 56 | 30/04/18 |
| Investor Relations Contact | - | - | |
| Corporate Officer/Principal | - | 31/12/19 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sherilyn McCoy
CHM | Chairman | 65 | - |
Duncan MacDonald
CEO | Chief Executive Officer | 56 | - |
May Kin Ho
BRD | Director/Board Member | 71 | 25/08/15 |
Eric Liu
BRD | Director/Board Member | 47 | 31/10/21 |
William Chase
BRD | Director/Board Member | 57 | - |
John Groetelaars
BRD | Director/Board Member | 58 | 22/06/23 |
Michael Bruun
BRD | Director/Board Member | - | 22/06/23 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 51,115,310 | 50,131,867 ( 98.08 %) | 0 | 98.08 % |
Company contact information
PAREXEL International Corp.
275 Grove Street Suite 101C
02466, Newton
+617 454 9300
http://www.parexel.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +2.15% | 42.75B | |
| +47.70% | 41.61B | |
| +12.03% | 41.34B | |
| -12.36% | 26.59B | |
| +8.04% | 25.49B | |
| -23.73% | 18.12B | |
| +30.13% | 12.24B | |
| -1.95% | 11.76B | |
| +8.10% | 11B |
